Providing for medication error prevention training.
HB1280 would amend Pennsylvania’s Pharmacy Act to require the State Board of Pharmacy to create a medication error prevention training program for licensed pharmacists, pharmacy technicians, and pharmacy technician trainees. The program must be taught by a board-approved instructor, use a board-approved curriculum and exam, and cover topics such as the pharmacist’s and prescriber’s roles, patient rights to accept or refuse medication, medication categories and effects, overdose and poisoning response, storage and disposal, communication with patients or guardians, and the six “rights” of medication administration: correct medication, dose, person, time, method, and documentation.
The bill also requires participants to demonstrate competency through an examination and to receive certification upon successful completion, including scoring at least 80 percent and showing knowledge of the medication’s name, purpose, side effects, and special instructions. Training would be required annually for pharmacists, technicians, and trainees, and pharmacists licensed in Pennsylvania for less than five years would need to complete the certification twice per year until they reach five years of licensure. The act would take effect 180 days after enactment.
HB1280 would add a new section to the Pharmacy Act and impose a new continuing training requirement on pharmacy personnel in Pennsylvania. It would expand the State Board of Pharmacy’s responsibilities by directing it to develop, approve, and oversee a standardized medication error prevention curriculum, instructor approval process, and examination/certification system. The bill would affect pharmacists, pharmacy technicians, and trainees statewide, with an enhanced training frequency for newer pharmacists.
Based on the bill text and the absence of recorded committee testimony or votes, the measure appears to be framed as a patient-safety and professional-standards bill rather than a controversial policy change. Its stated purpose is to reduce medication errors through recurring education and competency testing, which suggests a generally favorable public-health rationale. No formal opposition, amendments, or recorded vote history is available in the provided materials.
The main potential point of contention is the added regulatory and time burden on pharmacists, pharmacy technicians, and trainees, especially the requirement for annual training and twice-yearly certification for pharmacists licensed less than five years. Some stakeholders may also question the administrative workload for the State Board of Pharmacy, including approving instructors, curricula, and exams. However, no specific objections, supporters, or negotiated compromises are reflected in the provided committee record.